http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106975100-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L26-0061 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L26-0004 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L26-00 |
| filingDate | 2016-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106975100-B |
| titleOfInvention | A kind of nanocomposite and its preparation method and application of cerium oxide/mesoporous silicon |
| abstract | The present invention relates to a kind of nanocomposite of cerium oxide/mesoporous silicon, the cerium oxide nanocrystal of cerium oxide nanocrystal and amido modified nanometer particle comprising ligand conversion, ligand conversion is modified in the surface of amido modified nanometer particle；The mass ratio of cerium oxide nanocrystal that ligand is converted and amido modified nanometer particle is 1~20；The cerium oxide nanocrystal of ligand conversion carries out ligand conversion using 2- bromo acid.The invention further relates to the preparation method of cerium oxide/mesoporous silicon nanocomposite and its applications in wound healing or tissue repair.The active oxygen radical that the composite material can balance the surface of a wound is horizontal, reduces level of inflammation, plays adhesive effect using nanometer bridge effect；And preparation reaction system is mild, and condition is controllable, and prepared material all has good biocompatibility, has good clinical conversion possibility. |
| priorityDate | 2016-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 46.